Tilia Fe Kit
Product Images NDC 51862-896

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tilia Fe (NDC 51862-896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

Chemical structure diagrams of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Tilia Fe, a prescription drug kit by Mayne Pharma Inc.*

FDA Label Image

Image (Image 02)

Two line graphs showing mean steady-state plasma concentrations of Ethinyl Estradiol and Norethindrone over 24 hours following chronic administration of Norethindrone Acetate and Ethinyl Estradiol tablets. The left graph displays Ethinyl Estradiol concentrations (pg/mL) and the right graph displays Norethindrone concentrations (ng/mL), each at three different dose ratios labeled 1/20, 1/30, and 1/35.*

FDA Label Image

Image (Image 03)

Table showing mean (SD) steady-state pharmacokinetic parameters following chronic administration of Norethindrone Acetate and Ethinyl Estradiol tablets. The parameters include Cmax (maximum plasma concentration), AUC (area under the plasma concentration-time curve), CL/F (apparent oral clearance), and SHBG baseline values, detailed by dose (mg/µg) and cycle day for both Norethindrone and Ethinyl Estradiol.*

FDA Label Image

Image (Image 04)

A line graph showing the mean percent reduction in total lesion counts from baseline to each 28-day cycle for NDAc/EE Tablets compared to placebo, along with a data table of mean total lesion counts for NDAc/EE Tablets (N=296) and placebo (N=295) across six cycles. The graph illustrates changes for the intent-to-treat population over cycles 1 to 6.*

FDA Label Image

Image (Image 05)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It compares mortality rates among ever-users and controls of oral contraceptives, divided by smoking status (non-smokers and smokers) across four age groups: 15-24, 25-34, 35-44, and 45+. Mortality rates increase with age, with the highest rates seen in ever-users who smoke in the 45+ age group.*

FDA Label Image

Image (Image 06)

A data table titled 'Annual Number of Birth-Related or Method-Related Deaths Associated with Control of Fertility Per 100,000 Nonsterile Women by Fertility Control Method According to Age.' It presents death rates by fertility control methods across age groups 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44. Methods include no fertility control methods, oral contraceptives for non-smokers and smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with footnotes distinguishing birth-related and method-related deaths.*

FDA Label Image

Image (Image 07)

Illustration showing dosing instructions for Tilia Fe kit tablets. It depicts a hand placing a day label sticker on the blister pack to align days of the week with pills. The pack has four rows of colored tablets: pale yellow (5 active), light yellow (7 active), light brown (9 active), and brown (7 non-active). An arrow indicates to take pills left to right, starting at the indicated positions for Sunday or Day 1 starters.*

FDA Label Image

Image (Image 08)

A data table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The methods listed include no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates provided for age groups 15-19 through 40-44 years.*

FDA Label Image

Image (Image 09)

An instructional diagram showing how to start taking Tilia Fe NdAc and EE Tablets and Ferrous Fumarate Tablets KIT by day of the week. It illustrates placement of a day label sticker, the order to take pills from left to right, and color-coded pill counts including pale yellow (5 active tablets), light yellow (7 active tablets), light brown (9 active tablets), and brown (7 non-active tablets). A hand is shown applying a Monday day label sticker at the top of the kit.*

FDA Label Image

Image (Image 10)

FDA Label Image

Image-01 (Image 11)

Packaging label for Tilia Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), a human prescription drug kit by Mayne Pharma Inc. The label shows product strengths as 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg. The kit includes 3 blister cards each containing 28 tablets. The label contains usage warnings and storage instructions, along with barcodes and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.